Pulmonary complications associated with combination chemotherapy programs containing bleomycin

Am J Med. 1983 Apr;74(4):557-63. doi: 10.1016/0002-9343(83)91009-4.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols*
  • Bleomycin / adverse effects*
  • Cisplatin / adverse effects
  • Cyclophosphamide / adverse effects
  • Dexamethasone / adverse effects
  • Doxorubicin / adverse effects
  • Drug Interactions
  • Drug Therapy, Combination
  • Female
  • Humans
  • Leucovorin / adverse effects
  • Lung Diseases / chemically induced*
  • Lymphoma / drug therapy
  • Male
  • Methotrexate / adverse effects
  • Pulmonary Fibrosis / chemically induced
  • Respiratory Distress Syndrome / chemically induced
  • Testicular Neoplasms / drug therapy
  • Vinblastine / adverse effects
  • Vincristine / adverse effects

Substances

  • Bleomycin
  • Vincristine
  • Vinblastine
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin
  • Leucovorin
  • Methotrexate

Supplementary concepts

  • M-BACOD protocol
  • PVB protocol